Selected research
Market Outlook & Growth Opportunities
Global Marine Excipient Market Outlook and Growth Opportunities 2026
Market perspective
The global Marine Excipient market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Marine Excipient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Marine Excipient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Marine Excipient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Marine Excipient market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Marine Excipient market include Blue Biotech, Earthrise, Roquette Kloetze, Rizhao Jiejing Ocean Biotechnology Development Co., LTD, China, AlgaNovo International Co., Ltd, China, Yigeda Bio-Technology Co., Ltd, China, EID Parry, BASF (Cognis Australia, Betatene/BASF (DE) and Natural Beta Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Marine Excipient market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Marine Excipient and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Marine Excipient sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Marine Excipient market size, projected growth trends, production technologies, key applications, and end-use industries.
Marine Excipient Segment by Company
Blue Biotech
Earthrise
Roquette Kloetze
Rizhao Jiejing Ocean Biotechnology Development Co., LTD, China
AlgaNovo International Co., Ltd, China
Yigeda Bio-Technology Co., Ltd, China
EID Parry
BASF (Cognis Australia, Betatene/BASF (DE)
Natural Beta Technologies
Cyanotech
Mera Pharma
BioReal
US Nutra
AlgaTech
SandaKing
DIC Lifetec
Marcel Carrageenan
Zamboanga Carrageenan
Multicipta Infodevindo,
PT Sumber Alam Lestari
Meck Pharmaceuticals & Chemicals Pvt. Ltd.
Marine Excipient Segment by Type
Marine Food Accessories
Marine Pharmaceutical Excipients
Marine Cosmetics Accessories
Marine Excipient Segment by Application
Food Industry
Pharmaceutical Industry
Cosmetics Industry
Marine Excipient Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Marine Excipient status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Marine Excipient market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Marine Excipient significant trends, drivers, influence factors in global and regions.
6. To analyze Marine Excipient competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Excipient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Marine Excipient and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Excipient.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Marine Excipient market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Marine Excipient industry.
Chapter 3: Detailed analysis of Marine Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Marine Excipient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Marine Excipient in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Marine Food Accessories
- Marine Pharmaceutical Excipients
- Marine Cosmetics Accessories
Applications
- Food Industry
- Pharmaceutical Industry
- Cosmetics Industry
Companies covered
- Blue Biotech
- Earthrise
- Roquette Kloetze
- Rizhao Jiejing Ocean Biotechnology Development Co., LTD, China
- AlgaNovo International Co., Ltd, China
- Yigeda Bio-Technology Co., Ltd, China
- EID Parry
- BASF (Cognis Australia, Betatene/BASF (DE)
- Natural Beta Technologies
- Cyanotech
- Mera Pharma
- BioReal
- US Nutra
- AlgaTech
- SandaKing
- DIC Lifetec
- Marcel Carrageenan
- Zamboanga Carrageenan
- Multicipta Infodevindo,
- PT Sumber Alam Lestari
- Meck Pharmaceuticals & Chemicals Pvt. Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Marine Excipient Sales Value (2021-2032)
- 1.2.2 Global Marine Excipient Sales Volume (2021-2032)
- 1.2.3 Global Marine Excipient Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Marine Excipient Market Dynamics
- 2.1 Marine Excipient Industry Trends
- 2.2 Marine Excipient Industry Drivers
- 2.3 Marine Excipient Industry Opportunities and Challenges
- 2.4 Marine Excipient Industry Restraints
3 Marine Excipient Market by Company
- 3.1 Global Marine Excipient Company Revenue Ranking in 2025
- 3.2 Global Marine Excipient Revenue by Company (2021-2026)
- 3.3 Global Marine Excipient Sales Volume by Company (2021-2026)
- 3.4 Global Marine Excipient Average Price by Company (2021-2026)
- 3.5 Global Marine Excipient Company Ranking (2024-2026)
- 3.6 Global Marine Excipient Company Manufacturing Base and Headquarters
- 3.7 Global Marine Excipient Company Product Type and Application
- 3.8 Global Marine Excipient Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Marine Excipient Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Marine Excipient Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Marine Excipient Market by Type
- 4.1 Marine Excipient Type Introduction
- 4.1.1 Marine Food Accessories
- 4.1.2 Marine Pharmaceutical Excipients
- 4.1.3 Marine Cosmetics Accessories
- 4.2 Global Marine Excipient Sales Volume by Type
- 4.2.1 Global Marine Excipient Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Marine Excipient Sales Volume by Type (2021-2032)
- 4.2.3 Global Marine Excipient Sales Volume Share by Type (2021-2032)
- 4.3 Global Marine Excipient Sales Value by Type
- 4.3.1 Global Marine Excipient Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Marine Excipient Sales Value by Type (2021-2032)
- 4.3.3 Global Marine Excipient Sales Value Share by Type (2021-2032)
5 Marine Excipient Market by Application
- 5.1 Marine Excipient Application Introduction
- 5.1.1 Food Industry
- 5.1.2 Pharmaceutical Industry
- 5.1.3 Cosmetics Industry
- 5.2 Global Marine Excipient Sales Volume by Application
- 5.2.1 Global Marine Excipient Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Marine Excipient Sales Volume by Application (2021-2032)
- 5.2.3 Global Marine Excipient Sales Volume Share by Application (2021-2032)
- 5.3 Global Marine Excipient Sales Value by Application
- 5.3.1 Global Marine Excipient Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Marine Excipient Sales Value by Application (2021-2032)
- 5.3.3 Global Marine Excipient Sales Value Share by Application (2021-2032)
6 Marine Excipient Regional Sales and Value Analysis
- 6.1 Global Marine Excipient Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Marine Excipient Sales by Region (2021-2032)
- 6.2.1 Global Marine Excipient Sales by Region: 2021-2026
- 6.2.2 Global Marine Excipient Sales by Region (2027-2032)
- 6.3 Global Marine Excipient Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Marine Excipient Sales Value by Region (2021-2032)
- 6.4.1 Global Marine Excipient Sales Value by Region: 2021-2026
- 6.4.2 Global Marine Excipient Sales Value by Region (2027-2032)
- 6.5 Global Marine Excipient Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Marine Excipient Sales Value (2021-2032)
- 6.6.2 North America Marine Excipient Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Marine Excipient Sales Value (2021-2032)
- 6.7.2 Europe Marine Excipient Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Marine Excipient Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Marine Excipient Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Marine Excipient Sales Value (2021-2032)
- 6.9.2 South America Marine Excipient Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Marine Excipient Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Marine Excipient Sales Value Share by Country, 2025 VS 2032
7 Marine Excipient Country-level Sales and Value Analysis
- 7.1 Global Marine Excipient Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Marine Excipient Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Marine Excipient Sales by Country (2021-2032)
- 7.3.1 Global Marine Excipient Sales by Country (2021-2026)
- 7.3.2 Global Marine Excipient Sales by Country (2027-2032)
- 7.4 Global Marine Excipient Sales Value by Country (2021-2032)
- 7.4.1 Global Marine Excipient Sales Value by Country (2021-2026)
- 7.4.2 Global Marine Excipient Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.9.2 France Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.16.2 China Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.19.2 India Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Marine Excipient Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Marine Excipient Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Marine Excipient Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Marine Excipient Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Blue Biotech
- 8.1.1 Blue Biotech Company Information
- 8.1.2 Blue Biotech Business Overview
- 8.1.3 Blue Biotech Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Blue Biotech Marine Excipient Product Portfolio
- 8.1.5 Blue Biotech Recent Developments
- 8.2 Earthrise
- 8.2.1 Earthrise Company Information
- 8.2.2 Earthrise Business Overview
- 8.2.3 Earthrise Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Earthrise Marine Excipient Product Portfolio
- 8.2.5 Earthrise Recent Developments
- 8.3 Roquette Kloetze
- 8.3.1 Roquette Kloetze Company Information
- 8.3.2 Roquette Kloetze Business Overview
- 8.3.3 Roquette Kloetze Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Roquette Kloetze Marine Excipient Product Portfolio
- 8.3.5 Roquette Kloetze Recent Developments
- 8.4 Rizhao Jiejing Ocean Biotechnology Development Co., LTD, China
- 8.4.1 Rizhao Jiejing Ocean Biotechnology Development Co., LTD, China Company Information
- 8.4.2 Rizhao Jiejing Ocean Biotechnology Development Co., LTD, China Business Overview
- 8.4.3 Rizhao Jiejing Ocean Biotechnology Development Co., LTD, China Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Rizhao Jiejing Ocean Biotechnology Development Co., LTD, China Marine Excipient Product Portfolio
- 8.4.5 Rizhao Jiejing Ocean Biotechnology Development Co., LTD, China Recent Developments
- 8.5 AlgaNovo International Co., Ltd, China
- 8.5.1 AlgaNovo International Co., Ltd, China Company Information
- 8.5.2 AlgaNovo International Co., Ltd, China Business Overview
- 8.5.3 AlgaNovo International Co., Ltd, China Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.5.4 AlgaNovo International Co., Ltd, China Marine Excipient Product Portfolio
- 8.5.5 AlgaNovo International Co., Ltd, China Recent Developments
- 8.6 Yigeda Bio-Technology Co., Ltd, China
- 8.6.1 Yigeda Bio-Technology Co., Ltd, China Company Information
- 8.6.2 Yigeda Bio-Technology Co., Ltd, China Business Overview
- 8.6.3 Yigeda Bio-Technology Co., Ltd, China Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Yigeda Bio-Technology Co., Ltd, China Marine Excipient Product Portfolio
- 8.6.5 Yigeda Bio-Technology Co., Ltd, China Recent Developments
- 8.7 EID Parry
- 8.7.1 EID Parry Company Information
- 8.7.2 EID Parry Business Overview
- 8.7.3 EID Parry Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.7.4 EID Parry Marine Excipient Product Portfolio
- 8.7.5 EID Parry Recent Developments
- 8.8 BASF (Cognis Australia, Betatene/BASF (DE)
- 8.8.1 BASF (Cognis Australia, Betatene/BASF (DE) Company Information
- 8.8.2 BASF (Cognis Australia, Betatene/BASF (DE) Business Overview
- 8.8.3 BASF (Cognis Australia, Betatene/BASF (DE) Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.8.4 BASF (Cognis Australia, Betatene/BASF (DE) Marine Excipient Product Portfolio
- 8.8.5 BASF (Cognis Australia, Betatene/BASF (DE) Recent Developments
- 8.9 Natural Beta Technologies
- 8.9.1 Natural Beta Technologies Company Information
- 8.9.2 Natural Beta Technologies Business Overview
- 8.9.3 Natural Beta Technologies Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Natural Beta Technologies Marine Excipient Product Portfolio
- 8.9.5 Natural Beta Technologies Recent Developments
- 8.10 Cyanotech
- 8.10.1 Cyanotech Company Information
- 8.10.2 Cyanotech Business Overview
- 8.10.3 Cyanotech Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.10.4 Cyanotech Marine Excipient Product Portfolio
- 8.10.5 Cyanotech Recent Developments
- 8.11 Mera Pharma
- 8.11.1 Mera Pharma Company Information
- 8.11.2 Mera Pharma Business Overview
- 8.11.3 Mera Pharma Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.11.4 Mera Pharma Marine Excipient Product Portfolio
- 8.11.5 Mera Pharma Recent Developments
- 8.12 BioReal
- 8.12.1 BioReal Company Information
- 8.12.2 BioReal Business Overview
- 8.12.3 BioReal Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.12.4 BioReal Marine Excipient Product Portfolio
- 8.12.5 BioReal Recent Developments
- 8.13 US Nutra
- 8.13.1 US Nutra Company Information
- 8.13.2 US Nutra Business Overview
- 8.13.3 US Nutra Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.13.4 US Nutra Marine Excipient Product Portfolio
- 8.13.5 US Nutra Recent Developments
- 8.14 AlgaTech
- 8.14.1 AlgaTech Company Information
- 8.14.2 AlgaTech Business Overview
- 8.14.3 AlgaTech Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.14.4 AlgaTech Marine Excipient Product Portfolio
- 8.14.5 AlgaTech Recent Developments
- 8.15 SandaKing
- 8.15.1 SandaKing Company Information
- 8.15.2 SandaKing Business Overview
- 8.15.3 SandaKing Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.15.4 SandaKing Marine Excipient Product Portfolio
- 8.15.5 SandaKing Recent Developments
- 8.16 DIC Lifetec
- 8.16.1 DIC Lifetec Company Information
- 8.16.2 DIC Lifetec Business Overview
- 8.16.3 DIC Lifetec Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.16.4 DIC Lifetec Marine Excipient Product Portfolio
- 8.16.5 DIC Lifetec Recent Developments
- 8.17 Marcel Carrageenan
- 8.17.1 Marcel Carrageenan Company Information
- 8.17.2 Marcel Carrageenan Business Overview
- 8.17.3 Marcel Carrageenan Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.17.4 Marcel Carrageenan Marine Excipient Product Portfolio
- 8.17.5 Marcel Carrageenan Recent Developments
- 8.18 Zamboanga Carrageenan
- 8.18.1 Zamboanga Carrageenan Company Information
- 8.18.2 Zamboanga Carrageenan Business Overview
- 8.18.3 Zamboanga Carrageenan Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.18.4 Zamboanga Carrageenan Marine Excipient Product Portfolio
- 8.18.5 Zamboanga Carrageenan Recent Developments
- 8.19 Multicipta Infodevindo,
- 8.19.1 Multicipta Infodevindo, Company Information
- 8.19.2 Multicipta Infodevindo, Business Overview
- 8.19.3 Multicipta Infodevindo, Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.19.4 Multicipta Infodevindo, Marine Excipient Product Portfolio
- 8.19.5 Multicipta Infodevindo, Recent Developments
- 8.20 PT Sumber Alam Lestari
- 8.20.1 PT Sumber Alam Lestari Company Information
- 8.20.2 PT Sumber Alam Lestari Business Overview
- 8.20.3 PT Sumber Alam Lestari Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.20.4 PT Sumber Alam Lestari Marine Excipient Product Portfolio
- 8.20.5 PT Sumber Alam Lestari Recent Developments
- 8.21 Meck Pharmaceuticals & Chemicals Pvt. Ltd.
- 8.21.1 Meck Pharmaceuticals & Chemicals Pvt. Ltd. Company Information
- 8.21.2 Meck Pharmaceuticals & Chemicals Pvt. Ltd. Business Overview
- 8.21.3 Meck Pharmaceuticals & Chemicals Pvt. Ltd. Marine Excipient Sales, Value and Gross Margin (2021-2026)
- 8.21.4 Meck Pharmaceuticals & Chemicals Pvt. Ltd. Marine Excipient Product Portfolio
- 8.21.5 Meck Pharmaceuticals & Chemicals Pvt. Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Marine Excipient Value Chain Analysis
- 9.1.1 Marine Excipient Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Marine Excipient Sales Mode & Process
- 9.2 Marine Excipient Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Marine Excipient Distributors
- 9.2.3 Marine Excipient Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst